Medtronic Inc. Third Quarter Earnings Sneak Peek
Medtronic, Inc. Earnings Preview Cheat Sheet
Wall St. Earnings Expectations: The average analyst estimate is for net income of 84 cents per share, a decline of 2.3% from the company’s actual earnings for the year-ago quarter. During the past three months, the average estimate has moved down from 86 cents. Between one and three months ago, the average estimate moved down. It also has dropped from 85 cents during the last month. Analysts are projecting profit to rise by 2.4% compared to last year’s $3.45.
Past Earnings Performance: Last quarter, the company topped estimates by 0 cents, coming in at profit of 84 cents per share against a mean estimate of net income of 82 cents. The company fell in line with estimates in the first quarter.
Investing Insights: Will the iPad 3 Be the Next Catalyst for Apple’s Stock?
Wall St. Revenue Expectations: Analysts predict a rise of 1% in revenue from the year-earlier quarter to $4 billion.
Analyst Ratings: Analysts seem relatively indifferent about Medtronic with 13 of 25 analysts surveyed maintaining a hold rating.
A Look Back: In the second quarter, profit rose 53.9% to $871 million (82 cents a share) from $566 million (52 cents a share) the year earlier, exceeding analyst expectations. Revenue rose 5.9% to $4.13 billion from $3.9 billion.
Revenue has increased in each of the past four quarters. Revenue rose 7.3% in the first quarter from the year earlier, climbed 2.4% in the fourth quarter of the last fiscal year from the year-ago quarter and 2.9% in the third quarter of the last fiscal year.
After a two-quarter streak of year-over-year profit decreases, the company reported a profit increase in the second quarter. The figure dropped 1.1% in the first quarter and 18.7% in the fourth quarter of the last fiscal year.
Stock Price Performance: Between November 17, 2011 and February 15, 2012, the stock price rose $5.64 (16.8%), from $33.65 to $39.29. The stock price saw one of its best stretches over the last year between March 22, 2011 and March 30, 2011, when shares rose for seven straight days, increasing 4.8% (+$1.74) over that span. It saw one of its worst periods between May 18, 2011 and May 25, 2011 when shares fell for six straight days, dropping 6.9% (-$2.91) over that span.
(Company fundamentals by Xignite Financials. Earnings estimates provided by Zacks)
Don’t Miss These Additional Hot Stories:
To contact the reporter on this story: Derek Hoffman at firstname.lastname@example.org
To contact the editor responsible for this story: Damien Hoffman at email@example.com